Fludroxycortide Tape (previously known as Haelan® Tape) is a transparent medicated surgical tape.
Fludroxycortide Tape is impregnated with fludroxycortide, which is a corticosteroid (technically called a steroid).
Fludroxycortide Tape is used to help treat difficult cases of dermatitis and eczema especially when the skin is dry and scaly. It is also used in wound care to help prevent the development of proud flesh, technically known as excessive granular tissue which can hinder wound healing.
Fludroxycortide Tape is a Prescription Only Medicine. Prescription-only medicines, must be prescribed by a qualified health professional. This may be a GP, hospital doctor or pharmacist for example.
Fludroxycortide 4 micrograms per square centimetre tape. Always read the label
Like all medicines, corticosteroids including those applied to the skin can cause side effects, although not everybody gets them. Some patients may have one or more of the following side effects in the area where they apply
Infected wounds may take longer to heal. The amount of sugar in your blood and urine may change or some of your hormones may be affected causing weight gain, menstrual irregularities and hair growth. These effects are very rare. Some steroids are known to affect certain hormones. If your doctor thinks you need to be treated for longer periods of time, they may arrange for you to have hormone tests. If the product is affecting your hormones, your doctor may tell you to stop using it. Then your hormones should return to normal. Children treated with topical steroids have rarely had high fluid pressure in their skulls. This has caused headaches and swelling.
Adverse events and precautions
All medicines cause adverse events and should not be used in certain circumstances and by certain people with certain health issues. Please see the Patient Information Leaflet within Documentation Section above.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Patients and Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Typharm on 02037 694160.